Cell counting is a process used
in determining the cell count in individuals. This process is useful in
identifying the presence of infectious diseases. The prevalence of diseases
such as cancer and AIDS has made cell counting instruments such as flow cytometers
imperative for diagnosis and treatment in hospitals and clinics.The process plays a valuable role in determining the viability of cells in 3D cell culture. 3D cell culture is fundamental in researching viral vaccines and bolsters the development of stem cells to be used for transplantation purposes.
Automated
Instruments to Provide Novel Insights
The different types of cell
counting instruments used in clinical diagnosis include spectrophotometers,
flow cytometers, automated cell counters, and hemocytometers. The automated
cell counters segment is expected to grow at an ascending rate from 2014 to
2025 due to short test times and low error rates. The increasing use of
immunotherapy drugs for cancer treatment is expected to drive the demand for
this segment. The Vi-CELL XR automated cell analyzer by Beckman Coulter has the
ability to accurately count the number of dendritic cells required for
immunotherapy drugs.
The spectrophotometers segment
had captured a large market share in 2016 on account of increased healthcare
budgets of nations and introduction of magnified data visualization analysis
software in these devices. Advances in spectroscopy methods have provided
biologists additional tools to analyze bacteria strains and observe their
growth stages. For instance, the spectrophotometers by Mettler-Toledo
International, Inc., provide spectra and color analyses of large samples
simultaneously.
Market
Overview
According to a report by Grand
View Research, Inc., the global cell counting
market size is projected to touch USD 1.7 billion by
2025, growing at a 6.9% CAGR from 2014 to 2025 (forecast period). Prevalence of
chronic diseases such as AIDS and cancer and developments in stem cell research
are expected to spur market growth over the forecast period.
Use of data visualization
analysis software and demand for biopharmaceuticals are anticipated to bolster
market growth. Government initiatives encouraging research of cell therapeutics
will positively impact the market. But high prices of cell counting instruments
may act as a deterrent against growth. Key market players include Becton,
Dickinson (BD) and Company; Thermo Fisher Scientific, Inc.; Merck KGaA; and
Agilent Technologies.
In-Depth
Research Report On Cell Counting Market:
No comments:
Post a Comment